Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated mRNA Transport02:22

Regulated mRNA Transport

2.8K
2.8K
Experimental RNAi02:15

Experimental RNAi

6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference01:23

RNA Interference

26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flexible Porous Pomelo Pith Derived Janus Liquid Metal and Adhesive Hydrogel Hybrid Electronic Skins.

Smart medicine·2026
Same author

Copper homeostasis and cuproptosis in cancer: mitochondrial metabolic dependency and nanomedicine-based therapeutic strategies.

Apoptosis : an international journal on programmed cell death·2026
Same author

Diagnostic efficacy of ultrasound combined with fine-needle aspiration biopsy for papillary thyroid carcinoma based on C-TIRADS and ATA guidelines.

Frontiers in oncology·2026
Same author

Freeze-Derived Microporous Biomaterials for Tissue Engineering Applications.

Smart medicine·2026
Same author

Exosomal immune decoy integrates cfDNA scavenging and mTOR inhibition for synergistic lupus nephritis therapy.

Theranostics·2026
Same author

Hepatocellular Carcinoma-on-a-Chip Based on Microfluidic Well Array for Personalized Drug Evaluation.

Advanced healthcare materials·2026

Related Experiment Video

Updated: Jul 14, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K

Engineered mRNA Delivery Systems for Biomedical Applications.

Ji Wang1, Haofang Zhu1, Jingjing Gan1

  • 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.

Advanced Materials (Deerfield Beach, Fla.)
|October 8, 2023
PubMed
Summary

Messenger RNA (mRNA) therapeutics offer a promising approach to disease treatment. Optimizing mRNA structure and delivery enhances stability and protein expression, expanding therapeutic applications.

Keywords:
biomaterialsdelivery systemsmRNAparticlestherapeutics

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.1K

Related Experiment Videos

Last Updated: Jul 14, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.2K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.1K
Delivery of Modified mRNA in a Myocardial Infarction Mouse Model
06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.1K

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Therapeutics Development

Background:

  • Messenger RNA (mRNA) therapeutics have emerged as a powerful tool for disease prevention and treatment.
  • Optimization of mRNA structure and delivery systems has significantly improved stability, immunogenicity, and protein expression.

Purpose of the Study:

  • To provide a comprehensive analysis of mRNA structure optimization strategies.
  • To detail advancements in mRNA delivery systems.
  • To summarize the latest applications of mRNA technology in biomedical engineering.

Main Methods:

  • Review and analysis of existing literature on mRNA structure optimization.
  • Detailed description of various mRNA delivery systems.
  • Summary of recent advancements and applications in mRNA technology.

Main Results:

  • Engineered mRNA modifications enhance stability and protein expression.
  • Diverse delivery systems are crucial for effective mRNA therapeutics.
  • mRNA technology shows broad applicability in infectious diseases, cancer, protein replacement, and gene editing.

Conclusions:

  • mRNA therapeutics hold immense potential to revolutionize disease treatment.
  • Continued advancements in biomedical engineering are key to overcoming challenges and realizing the full potential of mRNA therapies.